<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kaasch AJ</submitter><funding>Bundesministerium für Bildung und Forschung</funding><funding>Deutsche Forschungsgemeinschaft</funding><funding>Paul-Ehrlich Gesellschaft für Chemotherapie</funding><pagination>ofz170</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6521783</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6(5)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The standard treatment duration in low-risk &lt;i>Staphylococcus aureus&lt;/i> bloodstream (SAB) is 14 days. However, it is unclear whether an extended course of antimicrobial therapy is necessary in patients with clinically uninfected prosthetic joints/osteosyntheses or pacemakers/automated implanted cardioverter-defibrillators (AICDs). Thus, we compared the duration of antimicrobial therapy and outcomes in patients with and those without clinically uninfected foreign bodies.&lt;h4>Methods&lt;/h4>We conducted a post hoc analysis of data from the prospective Invasive &lt;i>Staphylococcus aureus&lt;/i> Infection Cohort (INSTINCT) study. Adult low-risk patients who survived ≥4 days were assessed for duration of treatment, SAB-related events (attributable death, relapse, or new deep-seated i</pubmed_abstract><journal>Open forum infectious diseases</journal><pubmed_title>Effect of Clinically Uninfected Orthopedic Implants and Pacemakers/AICDs in Low-Risk &lt;i>Staphylococcus aureus&lt;/i> Bloodstream Infection on Crude Mortality Rate: A Post Hoc Analysis of a Large Cohort Study.</pubmed_title><pmcid>PMC6521783</pmcid><funding_grant_id>BMBF</funding_grant_id><funding_grant_id>01KI1017</funding_grant_id><funding_grant_id>01KN1106</funding_grant_id><funding_grant_id>KA 3104/1-1</funding_grant_id><pubmed_authors>Hellmich M</pubmed_authors><pubmed_authors>Kaasch AJ</pubmed_authors><pubmed_authors>Seifert H</pubmed_authors><pubmed_authors>Rieg S</pubmed_authors><pubmed_authors>Kern WV</pubmed_authors><pubmed_authors>Joost I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effect of Clinically Uninfected Orthopedic Implants and Pacemakers/AICDs in Low-Risk &lt;i>Staphylococcus aureus&lt;/i> Bloodstream Infection on Crude Mortality Rate: A Post Hoc Analysis of a Large Cohort Study.</name><description>&lt;h4>Background&lt;/h4>The standard treatment duration in low-risk &lt;i>Staphylococcus aureus&lt;/i> bloodstream (SAB) is 14 days. However, it is unclear whether an extended course of antimicrobial therapy is necessary in patients with clinically uninfected prosthetic joints/osteosyntheses or pacemakers/automated implanted cardioverter-defibrillators (AICDs). Thus, we compared the duration of antimicrobial therapy and outcomes in patients with and those without clinically uninfected foreign bodies.&lt;h4>Methods&lt;/h4>We conducted a post hoc analysis of data from the prospective Invasive &lt;i>Staphylococcus aureus&lt;/i> Infection Cohort (INSTINCT) study. Adult low-risk patients who survived ≥4 days were assessed for duration of treatment, SAB-related events (attributable death, relapse, or new deep-seated i</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 May</publication><modification>2026-05-01T04:56:29.773Z</modification><creation>2019-06-06T23:16:16Z</creation></dates><accession>S-EPMC6521783</accession><cross_references><pubmed>31111077</pubmed><doi>10.1093/ofid/ofz170</doi></cross_references></HashMap>